SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Parentheticals (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Deferred Financing Costs {1}
Amortization of deferred financing costs related to convertible debt	$ 0	$ 4,835
Research and Development
Clinical Studies expenses - fees, charges and related expenses	556,000	797,000
Stock Based Compensation
Compensation expenses recorded	302,559	43,667
Common shares from outstanding warrants	60,515,395	35,958,735
Common shares from convertible debentures and related accrued interest	12,402,393	12,117,873
Advertising Costs
Advertising costs are charged to operations when incurred	0	0
Concentrations of Credit Risk
Company maintains cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation ("FDIC") limit.	$ 250,000	$ 0